Brief: Immuneonco Biopharmaceuticals Shanghai Says Approval For Phase II Clinical Trial Of IMM251007/11/2023 10:28
Brief: Immuneonco Biopharmaceuticals Shanghai Says Obtained Investigational New Drug Approval16/10/2023 11:32
Brief: Immuneonco Biopharmaceuticals Shanghai Announces Subscription Of Wealth Management Product13/09/2023 16:07
Last trade - 00:00Last trade - 00:00Last trade - 00:00